Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia

European Respiratory Journal

Volumn 34, Issue 5, 2009, Pages 1148-1158

  Vardakas, K Z ^a,b   Matthaiou, D K ^a,b   Falagas, M E ^a,c  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pneumonia; Resistance; Staphylococcus aureus

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; COMMUNITY ACQUIRED PNEUMONIA; DISSEMINATED INTRAVASCULAR CLOTTING; FLU LIKE SYNDROME; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LEUKOPENIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RASH; REVIEW; SHOCK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; DISSEMINATED INTRAVASCULAR COAGULATION; EXOTOXINS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PNEUMONIA, STAPHYLOCOCCAL; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

EID: 71049144088     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00041009     Document Type: Review

References (129)

1. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998; 26: 1179-1181.
2. Zetola N, Francis JS, Nuermberger EL, et al. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005; 5: 275-286. (Pubitemid 40602247)
3. Kollef MH, Micek ST. Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen? Curr Opin Infect Dis 2006; 19: 161-168.
4. Kowalski TJ, Berbari EF, Osmon DR. Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clin Proc 2005; 80: 1201-1207.
5. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the United Kingdom. Eur Respir J 1997; 10: 1530-1534. (Pubitemid 27311067)
6. Niederman MS, McCombs JS, Unger AN, et al. The cost of treating community-acquired pneumonia. Clin Ther 1998; 20: 820-837.
7. Warren DK, Shukla SJ, Olsen MA, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31: 1312-1317.
8. Gosbell IB. Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA). Intern Med J 2005; 35: Suppl. 2, S120-S135. (Pubitemid 44933545)
9. Bradley SF. Staphylococcus aureus pneumonia: emergence of MRSA in the community. Semin Respir Crit Care Med 2005; 26: 643-649. (Pubitemid 43063075)
10. Micek ST, Kollef KE, Reichley RM, et al. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51: 3568-3573.
11. Morgan MS. Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents 2007; 30: 289-296.
12. Schultz KD, Fan LL, Pinsky J, et al. The changing face of pleural empysemas in children: epidemiology and management. Pediatrics 2004; 113: 1735-1740. (Pubitemid 38697984)
13. Feldman C, Ross S, Mahomed AG, et al. The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir Med 1995; 89: 187-192.
14. Rubinstein E, Kollef MH, Nathwani D. Pneumonia caused by Methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46: Suppl. 5, S378-S385. (Pubitemid 351717325)
15. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007; 45: 315-321.
16. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-759.
17. Lina G, Piémont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-1132.
18. Huijsdens XW, van Santen-Verheuvel MG, Spalburg E, et al. Multiple cases of familial transmission of community-acquired methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2006; 44: 2994-2996.
19. Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus infections in correctional facilities - Georgia, California, and Texas, 2001-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 992-996.
20. Diep BA, Sensabaugh GF, Somboona NS, et al. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol 2004; 42: 2080-2084.
21. Lindenmayer JM, Schoenfeld S, O'Grady R, et al. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998; 158: 895-899.
22. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin- resistant Staphylococcus aureus among professional football players. N Engl J Med 2005; 352: 468-475.
23. Campbell KM, Vaughn AF, Russell KL, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol 2004; 42: 4050-4053.
24. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections - Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep 2003; 52: 88.
25. Moreno F, Crisp C, Jorgensen JH, et al. Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis 1995; 21: 1308-1312.
26. Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39: 47-54.
27. Charlebois ED, Bangsberg DR, Moss NJ, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis 2002; 34: 425-433.
28. Baggett HC, Hennessy TW, Rudolph K, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004; 189: 1565-1573.
29. Landen MG, McCumber BJ, Asay ED, et al. Outbreak of boils in an Alaskan village: a case control study. West J Med 2000; 172: 235-239.
30. Centers for Disease Control and Prevention (CDC). Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders - Hawaii, 2001-2003. MMWR Morb Mortal Wkly Rep 2004; 53: 767-770.
31. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436-1444.
32. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-1771.
33. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia. Results from a large US Database of culture-positive pneumonia. Chest 2005; 128: 3854-3862.
34. Baldwin LN, Lowe AD. Panton-Valentine Leukocidin associated with community acquired methicillin resistant Staphylococcus aureus: a case report and review of interim guidelines. Anaesthesia 2008; 63: 764-766.
35. Dickson RP, Martinez SM, Ortiz JR. A Case of rapidly progressive necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus. Respir Care 2008; 53: 1223-1226.
36. Ebert MD, Sheth S, Fishman EK. Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of "mayhem in the lung". Emerg Radiol 2009; 16: 159-162.
37. Ho PL, Wong MP, Lai EL, et al. DNA typing of cytological samples for retrospective identification of an early case of Panton-Valentine Leucocidin-positive, community-associated methicillin-resistant Staphylococcus aureus pneumonia. J Clin Micobiol 2008; 46: 2457-2458.
38. Ito T, Iijima M, Fukushima T, et al. Pediatric pneumonia death caused by community-acquired methicillin-resistant Staphylococcus aureus, Japan. Emerg Infect Dis 2008; 14: 1312-1314.
39. Lee YP, Hoi WH, Wong RC. A case of Myopericarditis in a patient with methicillin-resistant Staphylococcus aureus community-acquired pneumonia. Ann Acad Med Singapore 2008; 37: 243-242.
40. Martino JL, McMillian WD, Polish LB, et al. Community-acquired methicillin-resistant Staphylococcus aureus pneumonia. Respir Med 2008; 102: 932-934.
41. Tong SY, Anstey NM, Lum GD, et al. Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia after influenza. Med J Aust 2008; 188: 61.
42. Valentini P, Parisi G, Monaco M, et al. An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report. Ann Clin Microbiol Antimicrob 2008; 7: 11.
43. Yee-Guardino S, Kumar D, Abughali N, et al. Recognition and treatment of neonatal community-associated MRSA pneumonia and bacteremia. Pediatr Pulmonol 2008; 43: 203-205.
44. Adam H, McGeer A, Simor A. Fatal case of post-influenza, community-associated MRSA pneumonia in an Ontario teenager with subsequent familial transmission. Can Commun Dis Rep 2007; 33: 45-48.
45. Agwu A, Brady KM, Ross T, et al. Cholera-like diarrhea and shock associated with community-acquired methicillin-resistant Staphylococcus aureus (USA400 clone) pneumonia. Pediatr Infect Dis J 2007; 26: 271-273.
46. Asnis D, Haralambou G, Tawiah P. Methicillin-resistant Staphylococcus aureus necrotizing pneumonia arising from an infected episiotomy site. Obstetr Gynecol 2007; 110: 188.
47. Balis E, Diacaki C, Tselioti P, et al. Community-acquired pneumonia and bacteremia due to methicillin-resistant Staphylococcus aureus carrying Panton-Valentine-leukocidin gene in Greece: two case reports and literature review. J Chemother 2007; 19: 703-708.
48. Creech CB, Johnson BG, Bartilson RE, et al. Increasing use of extracorporeal life support in methicillin-resistant Staphylococcus aureus sepsis in children. Pediatr Crit Care Med 2007; 8: 231-235.
49. Magira EE, Zervakis D, Routsi C, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: a lethal cause of pneumonia in an adult immunocompetent patient. Scand J Infect Dis 2007; 39: 466-469.
50. Nourse C, Starr M, Munckhof W. Community-acquired methicillin-resistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management. J Paediatr Child Health 2007; 43: 656-661.
51. Okhuysen-Cawley R, Prodhan P, Imamura M, et al. Management of abdominal compartment syndrome during extracorporeal life support. Pediatr Crit Care Med 2007; 8: 177-179. (Pubitemid 46568569)
52. Quadri AM, Hock YL. Pulmonary pathology of Panton-Valentine leukocidin gene carrying methicillin-resistant Staphylococcus aureus pneumonia. Histopathology 2007; 51: 712-713.
53. Risson DC, O'Connor ED, Guard RW, et al. A fatal case of necrotising pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. Med J Aust 2007; 186: 479-480. (Pubitemid 46806827)
54. Rotas M, McCalla S, Liu C, et al. Methicillin-resistant Staphylococcus aureus necrotizing pneumonia arising from an infected episiotomy site. Obstet Gynecol 2007; 109: 533-536. (Pubitemid 46151037)
55. Tronci M, Parisi G, Pantosti A, et al. CA-MRSA strain with decreased vancomycin susceptibility as a cause of serious invasive infection in an immunocompetent adolescent. Clin Microbiol Infect 2007; 13: Suppl. 1, S449.
56. Vayalumkal JV, Whittingham H, Vanderkooi O, et al. Necrotizing pneumonia and septic shock: suspecting CAMRSA in patients presenting to Canadian emergency departments. CJEM 2007; 9: 300-303. (Pubitemid 47232899)
57. Chua AP, Lee KH. Fatal bacteraemic pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus. Singapore Med J 2006; 47: 546-548. (Pubitemid 43900504)
58. Enayet I, Nazeri A, Johnson LB, et al. Community-associated methicillin-resistant Staphylococcus aureus causing chronic pneumonia. Clin Infect Dis 2006; 42: e57-e60.
59. Fortunov RM, Hulten KG, Hammerman WA, et al. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics 2006; 118: 874-881. (Pubitemid 46090027)
60. Garnier F, Tristan A, François B, et al. Pneumonia and new methicillin-resistant Staphylococcus aureus clone. Emerg Infect Dis 2006; 12: 498-500. (Pubitemid 43306281)
61. Gerogianni I, Mpatavanis G, Gourgoulianis K, et al. Combination of staphylococcal chromosome cassette SCCmec type V and Panton-Valentine leukocidin genes in a methicillin-resistant Staphylococcus aureus that caused necrotizing pneumonia in Greece. Diagn Microbiol Infect Dis 2006; 56: 213-216. (Pubitemid 44486636)
62. Hampson FG, Hancock SW, Primhak RA. Disseminated sepsis due to a Panton-Valentine leukocidin producing strain of community acquired meticillin resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy. Arch Dis Child 2006; 91: 201.
63. Jeyaratnam D, Reid C, Kearns A, et al. Community associated MRSA: an alert to paediatricians. Arch Dis Child 2006; 91: 511-512. (Pubitemid 43836105)
64. Jones TF, Creech CB, Erwin P, et al. Family outbreaks of invasive community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2006; 42: e76-e78.
65. Michalopoulos A, Falagas ME. Multi-systemic methicillin resistant Staphylococcus aureus (MRSA) community-acquired infection. Med Sci Monit 2006; 12: CS39-CS43.
66. Sabbatani F, Manfredi R, Marinacci G, et al. Community-acquired pneumonia and sepsis caused by multiresistant Staphylococcus aureus strain resulting in severe and long-lasting multiple organ inflammatory involvement. Eur J Inflam 2006; 4: 117-123. (Pubitemid 44317373)
67. Söderquist B, Berglund C, Strålin K. Community-acquired pneumonia and bacteremia caused by an unusual methicillin-resistant Staphylococcus aureus (MRSA) strain with sequence type 36, staphylococcal cassette chromosome mec type IV and Panton-Valentine leukocidin genes. Eur J Clin Microbiol Infect Dis 2006; 25: 604-606. (Pubitemid 44379696)
68. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005; 353: 1245-1251. (Pubitemid 41345946)
69. Conly J, Gilbert M, Zahang K, et al. Rapidly progressive fatal necrotizing pneumonitis (FNP) secondary to Panton-Valentine leukocidin (PVL)+ SCCmec type IVa community-acquired methicillin-resistant S. aureus (CAMRSA) - a harbinger of the future? Can J Infect Dis Med Microbiol 2005; 16: 109-110.
70. Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40: 100-107. (Pubitemid 40053465)
71. Frazee BW, Salz TO, Lambert L, et al. Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia in an immunocompetent young adult. Ann Emerg Med 2005; 46: 401-404. (Pubitemid 41552385)
72. Hsu LY, Tristan A, Koh TH, et al. Community-associated methicillin-resistant Staphylococcus aureus, Singapore. Emerg Infect Dis 2005; 11: 341-342.
73. Kravitz GR, Dries DJ, Peterson ML, et al. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005; 40: 941-947. (Pubitemid 40418298)
74. Martin BT, Palasanthiran P, Gosbell IB, et al. Severe childhood pneumonitis caused by the Queensland strain of community-acquired methicillin-resistant Staphylococcus aureus. Med J Aust 2005; 182: 249. (Pubitemid 40352793)
75. McAdams RM, Mazuchowski E, Ellis MW, et al. Necrotizing staphylococcal pneumonia in a neonate. J Perinatol 2005; 25: 677-679.
76. Monaco M, Antonucci R, Palange P, et al. Methicillin-resistant Staphylococcus aureus necrotizing pneumonia. Emerg Infect Dis 2005; 11: 1647-1648. (Pubitemid 41384367)
77. Micek ST, Dunne M, Kollef MH. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 2005; 128: 2732-2738. (Pubitemid 41507634)
78. Peleg AY, Munckhof WJ, Kleinschmidt SL, et al. Life-threatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia. Eur J Clin Microbiol Infect Dis 2005; 24: 384-387. (Pubitemid 40933912)
79. Schulz P, Allen M, Murray Q, et al. Infections due to community-acquired methicillin-resistant Staphylococcus aureus: an emergent epidemic in Kentucky. J Ky Med Assoc 2005; 103: 194-203.
80. Torell E, Molin D, Tano E, et al. Community-acquired pneumonia and bacteraemia in a healthy young woman caused by methicillin-resistant Staphylococcus aureus (MRSA) carrying the genes encoding Panton-Valentine leukocidin (PVL). Scand J Infect Dis 2005; 37: 902-904. (Pubitemid 43078100)
81. Tseng MH, Wei BH, Lin WJ, et al. Fatal sepsis and necrotizing pneumonia in a child due to community-acquired methicillin-resistant Staphylococcus aureus: case report and literature review. Scand J Infect Dis 2005; 37: 504-507.
82. Wang CM, Chuang CH, Chiu CH. Community-acquired disseminated methicillin-resistant Staphylococcus aureus infection: case report and clinical implications. Ann Trop Paediatr 2005; 25: 53-57. (Pubitemid 40372453)
83. Al-Tawfiq JA, Aldaabil RA. Community-acquired MRSA bacteremic necrotizing pneumonia in a patient with scrotal ulceration. J Infect 2005; 51: e241-e243.
84. Miklaševics E, Hæggman S, Balode A, et al. Report on the first PVL-positive community acquired MRSA strain in Latvia. Euro Surveill 2004; 9: 29-30.
85. Peleg AY, Munckhof WJ. Fatal necrotising pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (MRSA). Med J Aust 2004; 181: 228-229.
86. Boussaud V, Parrot A, Mayaud C, et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med 2003; 29: 1840-1843. (Pubitemid 37373837)
87. Mongkolrattanothai K, Boyle S, Kahana MD, et al. Severe Staphylococcus aureus infections caused by clonally related community-acquired methicillin-susceptible and methicillin-resistant isolates. Clin Infect Dis 2003; 37: 1050-1058. (Pubitemid 37323659)
88. Nimmo GR, Playford EG. Community-acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia. Med J Aust 2003; 178: 245.
89. van der Flier M, van Dijk NB, Fluit AC, et al. Fatal pneumonia in an adolescent due to community-acquired MRSA positive for Panton-Valentine- leukocidin. Ned Tijdschr Geneeskd 2003; 147: 1076-1079.
90. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin- resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis 2002; 35: 819-824.
91. Bitzan MM, Nagaraj SK, Georgitis JW, et al. Staphylococcus aureus pneumonia, hyponatremia, hypertension, proteinuria, and hematuria in a 14-year-old boy. Am J Kidney Dis 2000; 35: 354-359.
92. Gorak EJ, Yamada SM, Brown JD. Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors. Clin Infect Dis 1999; 29: 797-800. (Pubitemid 30256370)
93. From the Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota, 1997-1999. JAMA 1999; 282: 1123-1125.
94. Vassallo J, Galizia AC, Cuschieri P. Mixed pulmonary infection with Nocardia, Candida, MRSA, and group D Streptococcus species. Postgrad Med J 1996; 72: 680-681.
95. Dicpinigaitis PV, Levy DE, Gnass RD, et al. Pneumonia due to Staphylococcus aureus in a patient with AIDS: review of incidence and report of an atypical roentgenographic presentation. South Med J 1995; 88: 586-590.
96. Brian MJ, Michael A. Community-acquired infection with methicillin-resistant Staphylococcus aureus in Papua New Guinea. Pediatr Infect Dis J 1989; 8: 807-808. (Pubitemid 19284416)
97. Bedoui A, Braham M, Mahjoub B, et al. [Severe community acquired pneumonia due to Staphylococcus aureus in children. About two cases.]. Tunis Med 2006; 84: 666-669.
98. Bruno GJ, Bruno JM, Miyake AA. Community-acquired methicillin-resistant Staphylococcus aureus infection with fatal necrotizing pneumonia from lip abscess: a case report. J Oral Maxillofac Surg 2007; 65: 2350-2353. (Pubitemid 47610656)
99. Descloux E, Mohammedi I, Gillet Y, et al. Necrotizing pneumonia in an adult due to methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin. Reanimation 2007; 16: 256-258. (Pubitemid 46818149)
100. Teglia O, Gregorini E, Notario R, et al. Community-acquired methicillin-resistant Staphylococcus aureus. Rev Med Rosario 2007; 73: 76-81.
101. Luque Moreno A, Duran Núñez A, Bergadà Masó A, et al. Community-acquired, methicillin-resistant Staphylococcus aureus acute osteomyelitis and pneumonia. An Pediatr (Barc) 2008; 68: 373-376.
102. Barrios M, Alcolea A, Negreira S, et al. Necrotizing pneumonia due to community-acquired methicillin resistant Staphylococcus aureus in a pediatric patient. Enferm Infecc Microbiol Clin 2008; 26: 398-399. (Pubitemid 351879855)
103. Kuhn C, Markau S, Osten B. [Abscettic pneumonia in a renal transplantation female patient.]. Internist (Berl) 2005; 46: 789-794.
104. Sifuentes-Osornio J, Pérez-Patrigeon S. Sepsis caused by methicillin-resistant Staphylococcus aureus: the shadow of a persistent threat. Rev Invest Clin 2006; 58: 598-607. (Pubitemid 46455254)
105. Kallen AJ, Brunkard J, Moore Z, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 2009; 53: 258-365.
106. Castaldo ET, Yang EY. Severe sepsis attributable to community-associated methicillin-resistant Staphylococcus aureus: an emerging fatal problem. Am Surg 2007; 73: 684-687.
107. Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza - Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56: 325-329.
108. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-2004 influenza season. Emerg Infect Dis 2006; 12: 894-899.
109. Janvier J, Elsayed S, Gregson D, et al. Necrotising pneumonia secondary to community-associated methicillin-resistant S aureus (CAMRSA) USA300 strain without evidence of antecedent viral respiratory tract infection. Can J Infect Dis Med Microbiol 2006; 17: 310-315.
110. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115: 642-648. (Pubitemid 43378904)
111. Leroy O, Beuscart C, Garo B. Staphylococcal pulmonary infections. Med Mal Infect 1993; 23: 8-15.
112. Johnston BL. Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia - a critical review. Semin Respir Infect 1994; 9: 199-206. (Pubitemid 24310388)
113. Stankovic C, Mahajan PV, Asmar BI. Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia. Curr Infect Dis Rep 2007; 9: 223-227. (Pubitemid 46744738)
114. Buckingham SC, King MD, Miller ML. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J 2003; 22: 499-504.
115. Schultz KD, Fan LL, Pinsky J, et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 2004; 113: 1735-1740. (Pubitemid 38697984)
116. Alfaro C, Fergie J, Purcell K. Emergence of community-acquired Staphylococcus aureus in complicated parapneumonic effusions. Pediatr Infect Dis J 2005; 24: 274-276. (Pubitemid 40365868)
117. Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001; 286: 1201-1205. (Pubitemid 33015549)
118. Purcell K, Fergie J. Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children's Hospital. Arch Pediatr Adolesc Med 2005; 159: 980-985. (Pubitemid 41423339)
119. Marston BJ, Plouffe JF, File TM Jr, et al. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med 1997; 157: 1709-1718.
120. Trotter CL, Stuart JM, George R, et al. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis 2008; 14: 727-733.
121. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44: Suppl. 2, S27-S72. (Pubitemid 46290553)
122. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250. (Pubitemid 27044625)
123. Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164: 637-644. (Pubitemid 38392978)
124. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278: 2080-2084. (Pubitemid 28016230)
125. Siempos II, Vardakas KZ, Kopterides P, et al. Adjunctive therapies for community acquired pneumonia: a systematic review. J Antimicrob Chemother 2008; 62: 661-668.
126. Wunderink RG, Rello J, Cammarata SK, et al. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 2003; 124: 1789-1797. (Pubitemid 37433574)
127. Falagas ME, Siempos II, Vardakas KZ. Linezolid versus a glycopeptide or β-lactam for the treatment of Gram-positive bacterial infections: a meta-analysis of randomized controlled trials. Lancet Infectious Diseases 2008; 8: 53-66.
128. Bernardo K, Pakulat N, Fleer S, et al. Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 2004; 48: 546-555. (Pubitemid 38141715)
129. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007; 315: 1130-1133. (Pubitemid 46328024)